Abstract
Malignant mesothelioma is a rare tumor. The incidence has been rising since the 1970s with a male to female ratio of 5:1 which is likely due to the increased frequency of occupational exposure to asbestos in men. The clinical and imaging features of malignant mesothelioma vary widely depending on the stage of presentation. A significantly high index of suspicion is required to make a diagnosis due to the nonspecific nature of the symptoms, signs, and early radiology. Invasive surgical procedures are often required to obtain adequate tumor tissue samples to secure the diagnosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.
Verschraegen C. Mesothelioma: incidence and survival rates in the United States. Proc Am Soc Clin Oncol. 2003;22:869.
Bégin R. Asbestos related diseases. In: Harber P, Schenker MB, Balmes JR, editors. Occupational and environmental respiratory disease. St. Louis: Mosby-Year Book; 1996. p. 293–321.
Sheard JDH, et al. Pneumothorax and malignant mesothelioma in patients over the age of 40. Thorax. 1991;46:584–5.
Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982;37:810–5.
Ruffie P, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol. 1981;7:1157–68.
Olesen LL, Thorshauge H. Thrombocytosis in patients with malignant pleural mesothelioma. Cancer. 1988;62:1194–6.
Rudd RM. Malignant mesothelioma. Br Med Bull. 2010;93:105–23.
Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg. 2009;1(1):38–48.
Antman KH. Current concepts: malignant mesothelioma. N Engl J Med. 1980;303:200–2.
Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin Chest Med. 2006;27:193–213.
Gotfried MH, Quan SF, Sobonya RE. Diffuse epithelial pleural mesothelioma presenting as a solitary lung mass. Chest. 1983;84:99.
Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. Clin Radiol. 1999;54:415–21.
Mujoomdar AA, Sugarbaker DJ. Diffuse pleural malignancies. In: Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L, editors. Adult chest surgery. New York: McGraw Hill Medical; 2009. p. 838–48.
Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol. 1999;172:1039–47.
Bernard F, Sterman D, Smith RJ, et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;9:713–72.
Flores RM, Akhurst T, Gonen M, et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2003;126:11–6.
Flores RM, Akhurst T, Gonen M, et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2006;132:763–8.
Ismail-Khan R, Robinson LA, Williams CC, et al. Malignant pleural mesothelioma: a comprehensive review. Cancer Control. 2006;13:255–63.
Metintas M, Ozdemir N, Isiksoy S, et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma. J Comput Assist Tomogr. 1995;19:370–4.
Agarwal PP, Seely JM, Matzinger FR, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology. 2006;241:589–94.
Rai AJ, Flores RM, Mathew A, et al. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels. Clin Chem Lab Med. 2010;48(2):271–8.
Robinson BW, Creaney J, Lake R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003;362:1612–6.
West SD, Lee GYC. Management of malignant pleural mesothelioma. Clin Chest Med. 2006;27:335–54.
Butchart EG, Ashcroft T, Barnsley WC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 1976;31:15–24.
Edge SB, Byrd DR, Compton CC. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alam, N.Z., Flores, R.M. (2020). Malignant Mesothelioma: Clinical and Imaging Findings. In: Anttila, S., Boffetta, P. (eds) Occupational Cancers. Springer, Cham. https://doi.org/10.1007/978-3-030-30766-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-30766-0_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30765-3
Online ISBN: 978-3-030-30766-0
eBook Packages: MedicineMedicine (R0)